Cerebral postischemic hypoperfusion is mediated by ET(A) receptors

Brain Research

Volumn 726, Issue 1-2, 1996, Pages 242-246

  Spatz, Maria ^a   Yasuma, Yoshihide ^a   Strasser, Alois ^a   McCarron, Richard M ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Cerebral blood flow; Cerebral ischemia; Endothelin; Endothelin(A) receptor; Nitric oxide

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RINGER SOLUTION;

ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; GERBIL; LASER DOPPLER FLOWMETRY; NONHUMAN; PERFUSION; PRIORITY JOURNAL;

EID: 0030575316     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00409-X     Document Type: Article

References (31)

1. [1] Bacic, F., Uematsu, S., McCarron, R.M. and Spatz, M., Secretion of immunoreactive endothelin-1 by capillary and microvascular enzdothelium of human brain, Neurochem. Res., 17 (1992) 699-702.
2. [2] Barone, F.C., Globus, M.Y-T., Price, W.J., White, R.F., Storer, B.L., Feuerstein, G.Z., Busto, R. and Ohlstein, E.H., Endothelin levels increase in rat focal and global ischemia, J. Cereb. Blood Flow Metab., 14 (1994) 337-342.
3. [3] Boulanger, C. and Luscher, T., Release of endothelin from the porcine aorta: inhibition by endothelin-derived nitric oxide, J. Clin. Invest., 85 (1990) 587-590.
4. [4] Chang, C.J., Ishii, H., Yamamoto, H., Yamamoto, T. and Spatz, M., Effects of cerebral ischemia on regional dopamine release and D1 and D2 receptors, J. Neurochem., 60 (1993) 1483-1490.
5. A receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage intraci sternal but not intravenous injection, Life Sci., 52 (1993) 825-834.
6. [6] Dawson, D.A., Nitric oxide and focal cerebral ischemia: multiplicity of actions and diverse outcome, Cerebrovasc. Brain Metab. Rev., 6 (1994) 299-324.
7. [7] Ehrenreich, H., Lange, M., Near, K.A., Anneser, F., Schoeller, L.A., Schmid, R., Winkler, P.S., Kehrl, J.H., Schmiedek, P. and Goebel, F.D., Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-hr urine of patients with subarachnoid hemorrhage, Res. Exp. Med., 192 (1992) 257-268.
8. [8] Faraci, F.M., Effects of endothelin and vasopressin on cerebral blood vessels, Am. J. Physiol., 257 (1989) H799-H803.
9. [9] Feuerstein, G., Gu, J-L., Ohlstein, E.H., Barone, F.C. and Yue, T-L., Peptidic endothelin-1 receptor antagonist, BQ123, and neuroprotection, Peptides, 15 (1994) 467-469.
10. [10] Goligorsky, M.S., Tsukahara, H., Magazine, H., Anderson, T.T., Malik, A.B. and Bahou, W.F., Termination of endothelin signalling: role of nitric oxide, J. Cell Physiol., 158 (1994) 485-494.
11. [11] Haynes, W.G., Davenport, A.P. and Webb, D.J., Endothelin: progress in pharmacology and physiology, Trends Pharmacol. Sci., 14 (1993) 225-228.
12. [12] Hirata, Y. and Emori, T., Cellular mechanism of endothelin-induced nitric oxide synthesis by cultured bovine endothelial cells, J. Cardiovasc. Phamacol., 8 (1993) S225-S228.
13. [13] Hunley, T.E., Iwasaki, S., Homma, T. and Kon, V., Nitric oxide and endothelin in pathophysiological settings, Pediatr. Nephrol., 9 (1995) 235-424.
14. [14] Iadecola, C., Pelligrino, D.A., Moskowitz, M.A. and Lassen, N.A., Nitric oxide synthase inhibition and cerebrovascular regulation, J. Cereb. Blood Flow Metab., 14 (1994) 175-192.
15. G-nitro-L-arginine methyl ester in vivo, J. Cereb. Blood Flow Metab., 15 (Suppl 1) (1995) S458.
16. [16] Khraibi, A.A., Heublein, D.M. and Knox, F.G., Increased plasma level of endothelin-1 in the Okamoto spontaneously hypertensive rat, Mayo Clin. Proc., 68 (1993) 42-46.
17. [17] Kobari, M., Fukuuchi, Y., Tomita, M., Tanahashi, N., Konno, S. and Takeda, H., Constriction/dilation of the cerebral microvessels by intravascular endothelin-1 in cats, J. Cereb. Blood Flow Metab., 14 (1994) 64-69.
18. [18] Koseki, C., Imai, M., Hirata, Y., Yanigasawa, M. and Masaki, T., Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide? Am. J. Physiol., 256 (1989) R858-R866.
19. [19] MacCumber, M.W., Ross, A.C. and Snyder, S.H., Endothelin in the brain: receptors, mitogenesis, and biosynthesis in glial cells, Proc. Natl. Acad. Sci. USA. 87 (1990) 2359-2263.
20. [20] Macrae, I.M., Robinson, M.J., Graham, D.I., Reid, J.L. and McCulloch, J., Endothelin-1 induced reduction in cerebral blood flow: dose dependency, time course and neuropathological consequences, J. Cereb. Blood Flow Metab., 13 (1993) 276-284.
21. [21] Moncada, S., Palmer, R.M. and Higgs, E.A., Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol. Rev., 43 (1991) 109-142.
22. [22] Panza, JA., Quyyumi, A.A., Brush, J.E. Jr. and Epstein, S.E., Abnormal endothelin-dependent vascular relaxation in patients with essential hypertension, N. Engl. J. Med., 323 (1990) 22-27.
23. [23] Prado, R., Watson, B.D. and Webster, P., Effects of nitric oxide synthase inhibition on cerebral blood flow following bilateral carotid artery occlusion and recirculation in the rat, J. Cereb. Blood Flow Metab., 13 (1993) 720-723.
24. A receptors, Brain Res., 676 (1995) 141-150.
25. [25] Sakurai, T., Yanigasawa, M. and Masaki, T., Molecular characterization of endothelin receptors, Trends Pharmacol. Sci., 13 (1992) 103-108.
26. [26] Sancesario, G., Iannone, M., Morello, M., Nitisco, G. and Bernardi, G., Nitric oxide inhibition aggravates ischémie damage of hippocampal but not of NADPH neurons in gerbils, Stroke, 25 (1994) 436-443.
27. [27] Spatz, M., Stanimirovic, D., Strasser, A. and McCarron, R.M., Nitro-L-arginine augments the endothelin-1 content of cerebrospinal fluid induced by cerebral ischemia, Brain Res., 684 (1995) 99-102.
28. [28] Spatz, M., Stanimirovic, D. and McCarron, R.M., Endothelin as a mediator of blood-brain barrier function. In J. Greenwood, D.J. Begley and M.B. Segal (Eds.), New Concepts of Blood - Brain Barrier, Plenum Press, Amsterdam, 1996, pp. 47-61.
29. [29] Strosznajder, J., Chalimoniuk, M., Samochocki, M. and Gadamski, R., Nitric oxide: a potent mediator of glutamatergic neurotoxicity in brain ischemia, Ann. NY Acad. Sci., 723 (1994) 429-432.
30. [30] Suzuki, R., Masaoka, H., Hirata, Y., Marumo, F., Isotani, E, and Hirakawa, K., The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage, J. Neurosurg., 11 (1992) 96-100.
31. [31] Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. and Masaki. T., A novel potent vasoconstrictive peptide produced by endothelial cells, Nature, 332 (1988) 411-415.